HRP20030125B1 - Prodrugs to nmda receptor ligands - Google Patents
Prodrugs to nmda receptor ligandsInfo
- Publication number
- HRP20030125B1 HRP20030125B1 HR20030125A HRP20030125A HRP20030125B1 HR P20030125 B1 HRP20030125 B1 HR P20030125B1 HR 20030125 A HR20030125 A HR 20030125A HR P20030125 A HRP20030125 A HR P20030125A HR P20030125 B1 HRP20030125 B1 HR P20030125B1
- Authority
- HR
- Croatia
- Prior art keywords
- lower alkyl
- prodrugs
- nmda receptor
- receptor ligands
- ylid
- Prior art date
Links
- 102000004868 N-Methyl-D-Aspartate Receptors Human genes 0.000 title 1
- 108090001041 N-Methyl-D-Aspartate Receptors Proteins 0.000 title 1
- 239000003446 ligand Substances 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyclic tertiary amine Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/42—Oxygen atoms attached in position 3 or 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Biochemistry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00117918 | 2000-08-21 | ||
| PCT/EP2001/009561 WO2002016321A1 (de) | 2000-08-21 | 2001-08-20 | Prodrugs to nmda receptor ligands |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20030125A2 HRP20030125A2 (en) | 2005-02-28 |
| HRP20030125B1 true HRP20030125B1 (en) | 2011-07-31 |
Family
ID=8169594
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20030125A HRP20030125B1 (en) | 2000-08-21 | 2003-02-20 | Prodrugs to nmda receptor ligands |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6407235B1 (de) |
| EP (1) | EP1313703B1 (de) |
| JP (1) | JP4162991B2 (de) |
| KR (1) | KR100589991B1 (de) |
| CN (1) | CN1227230C (de) |
| AR (1) | AR030373A1 (de) |
| AT (1) | ATE386022T1 (de) |
| AU (2) | AU8589401A (de) |
| BR (1) | BR0113348A (de) |
| CA (1) | CA2419279C (de) |
| CY (1) | CY1107937T1 (de) |
| CZ (1) | CZ303319B6 (de) |
| DE (1) | DE60132782T2 (de) |
| DK (1) | DK1313703T3 (de) |
| EC (1) | ECSP034489A (de) |
| EG (1) | EG24293A (de) |
| ES (1) | ES2299508T3 (de) |
| HK (1) | HK1059083A1 (de) |
| HR (1) | HRP20030125B1 (de) |
| HU (1) | HU229802B1 (de) |
| IL (1) | IL154254A0 (de) |
| JO (1) | JO2289B1 (de) |
| MA (1) | MA26947A1 (de) |
| MX (1) | MXPA03001311A (de) |
| MY (1) | MY136065A (de) |
| NO (1) | NO324941B1 (de) |
| NZ (1) | NZ523990A (de) |
| PA (1) | PA8525601A1 (de) |
| PE (1) | PE20020291A1 (de) |
| PL (1) | PL204215B1 (de) |
| PT (1) | PT1313703E (de) |
| RS (1) | RS51467B (de) |
| RU (1) | RU2272027C2 (de) |
| SI (1) | SI1313703T1 (de) |
| WO (1) | WO2002016321A1 (de) |
| ZA (1) | ZA200300894B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001245891A1 (en) * | 2000-03-21 | 2001-10-03 | The Procter & Gamble Company | Heterocyclic side chain containing, n-substituted metalloprotease inhibitors |
| US6713490B2 (en) | 2002-04-26 | 2004-03-30 | Pfizer, Inc. | 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists |
| CA2633010A1 (en) * | 2005-12-19 | 2007-06-28 | Methylgene Inc. | Histone deacetylase inhibitors for enhancing activity of antifungal agents |
| EP2573069A3 (de) | 2006-12-19 | 2013-05-22 | MethylGene Inc. | Histondeacetylase-Hemmer und Prodrugs daraus |
| US8796330B2 (en) * | 2006-12-19 | 2014-08-05 | Methylgene Inc. | Inhibitors of histone deacetylase and prodrugs thereof |
| ES2733344T3 (es) | 2013-11-05 | 2019-11-28 | Astrazeneca Ab | Profármacos antagonistas de NMDA |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0824098A1 (de) * | 1996-07-19 | 1998-02-18 | F. Hoffmann-La Roche Ag | 4-Hydroxypiperidinderivate |
| WO2000075109A1 (en) * | 1999-06-08 | 2000-12-14 | F. Hoffmann-La Roche Ag | Ethanesulfonyl-piperidine derivatives |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4410822A1 (de) | 1994-03-24 | 1995-09-28 | Schering Ag | Neue Piperidin-Derivate |
-
2001
- 2001-08-16 PA PA20018525601A patent/PA8525601A1/es unknown
- 2001-08-16 US US09/931,431 patent/US6407235B1/en not_active Expired - Lifetime
- 2001-08-16 PE PE2001000820A patent/PE20020291A1/es not_active Application Discontinuation
- 2001-08-17 AR ARP010103939A patent/AR030373A1/es active IP Right Grant
- 2001-08-17 MY MYPI20013876A patent/MY136065A/en unknown
- 2001-08-19 JO JO2001136A patent/JO2289B1/en active
- 2001-08-20 CZ CZ20030492A patent/CZ303319B6/cs not_active IP Right Cessation
- 2001-08-20 KR KR1020037002485A patent/KR100589991B1/ko not_active IP Right Cessation
- 2001-08-20 DK DK01965201T patent/DK1313703T3/da active
- 2001-08-20 SI SI200130812T patent/SI1313703T1/sl unknown
- 2001-08-20 HU HU0301548A patent/HU229802B1/hu not_active IP Right Cessation
- 2001-08-20 DE DE60132782T patent/DE60132782T2/de not_active Expired - Lifetime
- 2001-08-20 CA CA002419279A patent/CA2419279C/en not_active Expired - Fee Related
- 2001-08-20 AU AU8589401A patent/AU8589401A/xx active Pending
- 2001-08-20 MX MXPA03001311A patent/MXPA03001311A/es active IP Right Grant
- 2001-08-20 JP JP2002521197A patent/JP4162991B2/ja not_active Expired - Fee Related
- 2001-08-20 PT PT01965201T patent/PT1313703E/pt unknown
- 2001-08-20 EP EP01965201A patent/EP1313703B1/de not_active Expired - Lifetime
- 2001-08-20 RU RU2003107572/04A patent/RU2272027C2/ru not_active IP Right Cessation
- 2001-08-20 AU AU2001285894A patent/AU2001285894B2/en not_active Ceased
- 2001-08-20 EG EG20010906A patent/EG24293A/xx active
- 2001-08-20 CN CNB01814361XA patent/CN1227230C/zh not_active Expired - Fee Related
- 2001-08-20 PL PL361387A patent/PL204215B1/pl unknown
- 2001-08-20 WO PCT/EP2001/009561 patent/WO2002016321A1/de active IP Right Grant
- 2001-08-20 AT AT01965201T patent/ATE386022T1/de active
- 2001-08-20 RS YUP-130/03A patent/RS51467B/sr unknown
- 2001-08-20 ES ES01965201T patent/ES2299508T3/es not_active Expired - Lifetime
- 2001-08-20 IL IL15425401A patent/IL154254A0/xx not_active IP Right Cessation
- 2001-08-20 BR BR0113348-9A patent/BR0113348A/pt not_active Application Discontinuation
- 2001-08-20 NZ NZ523990A patent/NZ523990A/en not_active IP Right Cessation
-
2003
- 2003-01-31 ZA ZA200300894A patent/ZA200300894B/en unknown
- 2003-02-19 NO NO20030781A patent/NO324941B1/no not_active IP Right Cessation
- 2003-02-20 EC EC2003004489A patent/ECSP034489A/es unknown
- 2003-02-20 HR HR20030125A patent/HRP20030125B1/xx not_active IP Right Cessation
- 2003-02-21 MA MA27052A patent/MA26947A1/fr unknown
-
2004
- 2004-03-16 HK HK04101906A patent/HK1059083A1/xx not_active IP Right Cessation
-
2008
- 2008-05-08 CY CY20081100485T patent/CY1107937T1/el unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0824098A1 (de) * | 1996-07-19 | 1998-02-18 | F. Hoffmann-La Roche Ag | 4-Hydroxypiperidinderivate |
| WO2000075109A1 (en) * | 1999-06-08 | 2000-12-14 | F. Hoffmann-La Roche Ag | Ethanesulfonyl-piperidine derivatives |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ID17851A (id) | Persenyawaan heterosiklis, produksi dan pemakaiannya | |
| ATE209645T1 (de) | Neue verbindung, verfahren zu ihrer herstellung und antitumormittel | |
| CO4750662A1 (es) | DERIVADOS DE BENZO (g) QUINOLINA | |
| RS52001B (en) | NEW DIAZENIUM DIIOLATE DERIVATIVES, PROCEDURE OF THEIR PRODUCTION AND THE PHARMACEUTICAL MIXTURES CONTAINING THEM | |
| HRP20030125B1 (en) | Prodrugs to nmda receptor ligands | |
| TNSN07395A1 (en) | Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives | |
| IS6452A (is) | Ný tetrahýdrópýridín, framleiðsluaðferð og lyfjasamsetningar sem innihalda þau | |
| HUP9801089A2 (hu) | Benzolszulfonamidszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| MXPA02012569A (es) | Ftalidas substituidas novedosas, un procedimiento para su preparacion y las composiciones farmaceuticas que contienen a las mismas. | |
| TW200745153A (en) | Trehalose compound and pharmaceutical comprising the compound | |
| EA200100969A1 (ru) | Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции | |
| MY125037A (en) | 1,2,3,4 tetrahydroquinoline derivatives | |
| HRP20031055B1 (en) | Novel immunomodulating compounds | |
| ATE148128T1 (de) | Anthracyclinglycosid-derivate und verfahren zu ihrer herstellung | |
| CA2364199A1 (fr) | Nouveaux derives bicycliques d'amino-pyrazinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MEP12408A (en) | Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors | |
| HUP0201195A2 (hu) | Új vegyületek, eljárás előállításukra, felhasználásuk pigmentként és kozmetikai készítményekként | |
| FR2826005B1 (fr) | Synthese totale de la galanthamine, de ses analogues et de ses derives | |
| BR0113907A (pt) | Derivados bifenilas substituìdos, o respectivo processo de preparação e as composições farmacêuticas que os contêm | |
| TR199901394T2 (xx) | NMDA antagonistleri haz�rlanmas� i�in i�lem | |
| MY132324A (en) | New piperazine derivatives and methods for the preperation thereof and compositions containing the same | |
| BR0115809A (pt) | Processo de ciclização para sìntese de compostos derivados de pirolidina | |
| IL74877A0 (en) | 9-halogen prostaglandin derivatives,process for the preparation thereof and pharmaceutical compositions containing the same | |
| MX9603308A (es) | Nuevos derivados piperazina y metodos para su preparacion y composicion que los contiene. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| B1PR | Patent granted | ||
| PPPP | Transfer of rights |
Owner name: EVOTEC INTERNATIONAL GMBH, DE |
|
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20140728 Year of fee payment: 14 |
|
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20150820 |